Wells Fargo & Company Avidity Biosciences, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 133,873 shares of RNA stock, worth $5.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,873

Previous 157,975 15.26%

Holding current value

$5.67 Million

Previous $4.03 Million 35.65%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$22.73 - $40.85 $547,838 - $984,566	-24,102 Reduced 15.26%	133,873 $5.47 Million
Q1 2024 May 10, 2024	SELL	$9.16 - $25.52 $300,017 - $835,856	-32,753 Reduced 17.17%	157,975 $4.03 Million
Q4 2023 Feb 09, 2024	SELL	$4.87 - $9.37 $50,643 - $97,438	-10,399 Reduced 5.17%	190,728 $1.73 Million
Q3 2023 Nov 13, 2023	SELL	$6.3 - $11.35 $143,457 - $258,450	-22,771 Reduced 10.17%	201,127 $1.28 Million
Q2 2023 Aug 15, 2023	BUY	$10.62 - $17.34 $973,588 - $1.59 Million	91,675 Added 69.33%	223,898 $2.48 Million
Q1 2023 May 12, 2023	BUY	$15.35 - $25.65 $1.21 Million - $2.02 Million	78,896 Added 147.95%	132,223 $2.03 Million
Q4 2022 Feb 13, 2023	SELL	$10.06 - $22.66 $7,162 - $16,133	-712 Reduced 1.32%	53,327 $1.18 Million
Q3 2022 Nov 14, 2022	SELL	$15.46 - $23.43 $440,687 - $667,872	-28,505 Reduced 34.53%	54,039 $882,000
Q2 2022 Aug 12, 2022	BUY	$11.18 - $20.5 $17,161 - $31,467	1,535 Added 1.89%	82,544 $1.2 Million
Q1 2022 May 16, 2022	SELL	$14.2 - $23.78 $635,606 - $1.06 Million	-44,761 Reduced 35.59%	81,009 $1.5 Million
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $115,423 - $162,158	5,658 Added 4.71%	125,770 $2.99 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $969,798 - $1.35 Million	53,403 Added 80.05%	120,112 $2.96 Million
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $402,837 - $600,766	-20,532 Reduced 23.53%	66,709 $1.65 Million
Q1 2021 May 13, 2021	BUY	$20.28 - $28.15 $128,108 - $177,823	6,317 Added 7.81%	87,241 $1.9 Million
Q4 2020 Feb 09, 2021	BUY	$24.73 - $35.12 $681,484 - $967,801	27,557 Added 51.64%	80,924 $2.07 Million
Q3 2020 Nov 05, 2020	BUY	$23.35 - $35.94 $1.25 Million - $1.92 Million	53,367 New	53,367 $1.5 Million

Others Institutions Holding RNA

# of Institutions

206

Shares Held

95.5M

Call Options Held

171K

Put Options Held

196K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.21B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Avidity Biosciences, Inc. Transaction History